Breaking:

MD Anderson - MD Anderson Cancer Center | BioNews Texas

Sort posts

MD Anderson Study Finds Proton Therapy Less Costly Than Conventional Techniques For Early Stage Breast Cancer

MD Anderson Study Finds Proton Therapy Less Costly Than Conventional Techniques For Early Stage Breast Cancer

According to new research from The University of Texas MD Anderson Proton Therapy Center at Houston, early stage breast cancer patients may benefit from accelerated partial breast irradiation (APBI) using proton therapy as opposed to conventional whole breast irradiation (WBI) in terms of duration and cost of treatment. APBI is a localized form of radiation treatment (brachytherapy) that involves the ...

Read More »

Two More MD Anderson Leaders Elected to the Institute of Medicine

Two More MD Anderson Leaders Elected to the Institute of Medicine

A pair of accomplished healthcare industry leaders from the University of Texas MD Anderson Cancer Center have just been appointed to head separate departments at the National Academies‘ Institute of Medicine (IOM). The two have made immeasurable contributions to the field of medicine and health, and MD Anderson believes that they are sure to bring about more change and improvements from ...

Read More »

Entire Lobe Of Lung Removal More Effective Than Partial Resection To Early-Stage Lung Cancer Patients

Entire Lobe Of Lung Removal More Effective Than Partial Resection To Early-Stage Lung Cancer Patients

According to a recent study from The University of Texas MD Anderson Cancer Center, the removal of the entire lobe of the lung in patients with early-stage lung cancer, rather than the partial resection, may offer better overall survival. In addition, stereotactic ablative radiotherapy (SABR) may offer the exact same survival benefit as a lobectomy for some patients. Published in JAMA Surgery, it is the largest population ...

Read More »

Genomic Heterogeneity Varies Across Different Cancers, MD Anderson Study Suggests

Genomic Heterogeneity Varies Across Different Cancers, MD Anderson Study Suggests

Two years ago, a study on renal cell cancer became a turning point in the way oncologists viewed the efficacy of drawing a biopsy from only one region of a tumor. The findings suggested this method did not allow a comprehensive enough representation of all the cancer-driving genetic abnormalities needed to properly examine the tumor. Just recently, however, a team ...

Read More »

CPRIT-Funded MD Anderson, University of Houston Cancer Initiative Targets Smoking Cessation in Mental Health Patients

CPRIT-Funded MD Anderson, University of Houston Cancer Initiative Targets Smoking Cessation in Mental Health Patients

A partnership between MD Anderson and anti-tobacco programs led by the University of Houston and Austin Travis County Integral Care (ATCIC) is currently underway to extend cancer prevention efforts. As part of the effort, researchers are focused on educating mental health providers to help tobacco users eliminate their addiction within mental health facilities. There are 19 Local Mental Health Authorities ...

Read More »

MD Anderson Adds 15 New Members to Board of Visitors

MD Anderson Adds 15 New Members to Board of Visitors

The University of Texas MD Anderson Cancer Center is at the forefront of personalized, cutting edge cancer care. It is also supports comprehensive and novel research and development efforts from some of the most accomplished scientists and academics in the country. To further its mission to eradicate cancer in the state of Texas, the country, and the rest of the ...

Read More »

MD Anderson Study Finds Cancer Cells Adapt Energy Needs to Metastasize to Other Organs

MD Anderson Study Finds Cancer Cells Adapt Energy Needs to Metastasize to Other Organs

Houston’s University of Texas MD Anderson Cancer Center says that if you want to understand why cancer cells metastasize — think of Sparta, the Greek city-state that as a political and military power spanned the cusp of the bronze and early iron ages from about 650 BC to the Roman conquest in 146 BC. Spartan warriors were fed a special ...

Read More »

Prominent Radiation Oncologist Joins MD Anderson

Prominent Radiation Oncologist Joins MD Anderson

It is estimated that almost two-thirds of cancer patients will receive radiation therapy (RT) during the course of their disease. This underscores the importance of constantly providing the healthcare system with advanced technology, and personalized, evidence-based approaches to treating cancer with RT. The University of Texas MD Anderson Cancer Center has a new head of the division of radiation oncology, ...

Read More »

Breast Conservation Therapy May Be Better than a Mastectomy, According to MD Anderson Researchers

Breast Conservation Therapy May Be Better than a Mastectomy, According to MD Anderson Researchers

Among the most commonly diagnosed cancer, and most prevalent cause of cancer death in women is breast cancer; estimated to affect 1 out of every 8 women. Out of the approximately 220,000 American women who will be diagnosed with breast cancer this year, 40,000 will die of it. Even with today’s cutting edge research technology, much remains to be discovered about ...

Read More »

MD Anderson Scientists Find Novel Immunotherapy/Vaccine Combo Decreases HER2 Positive Breast Cancer Recurrence

MD Anderson Scientists Find Novel Immunotherapy/Vaccine Combo Decreases HER2 Positive Breast Cancer Recurrence

Research findings to be presented by The University of Texas MD Anderson Cancer Center at the American Society of Clinical Oncology’s 2014 Breast Cancer Symposium in San Francisco report that a new vaccine candidate for treating breast cancer, known as GP2, has been shown to inhibit the recurrence of the disease according to recent studies. The vaccines were shown to ...

Read More »

MD Anderson Reports Proton Beam Therapy is Cheaper than IMRT in Long Run For Some Cancers

MD Anderson Reports Proton Beam Therapy is Cheaper than IMRT in Long Run For Some Cancers

An international manhunt for a five-year-old UK cancer patient whose parents sought out cutting-edge proton beam radiation therapy in Spain, against the wishes of UK public health authorities, has highlighted the rise of next-generation radiation therapy technologies that are more accurate and expose patients to less radiation. In response to an increase in interest about proton beam therapy, scientists from ...

Read More »

Memorial Hermann and MD Anderson to Expand Breast Screening and Care in Greater Houston

Memorial Hermann and MD Anderson to Expand Breast Screening and Care in Greater Houston

The Memorial Hermann Health System, together with The University of Texas MD Anderson Cancer Center, has just announced a new collaboration aimed at introducing an innovative method of breast screening that will be accessible to the community of breast care centers in Houston, Texas. Towards the end of November 2014, MD Anderson will officially be the sole source of professional breast ...

Read More »

New MD Anderson and Foundation Medicine Trial Focuses on Targeted Therapies For Metastatic Disease

New MD Anderson and Foundation Medicine Trial Focuses on Targeted Therapies For Metastatic Disease

The University of Texas MD Anderson Cancer Center recently partnered with Cambridge-based Foundation Medicine to conduct a clinical trial that will determine whether targeted therapies selected based on tumor molecular profiling leads to longer survival among patients with metastatic disease, compared to therapies that weren’t selected through this method. The study, entitled, Initiative for Molecular Profiling and Advanced Cancer Therapy, also known as “IMPACT2,” ...

Read More »

MD Anderson Breast Cancer Program Welcomes New Recruits

MD Anderson Breast Cancer Program Welcomes New Recruits

The Department of Breast Medical Oncology at MD Anderson has announced the addition of two new members to its team: Debu Tripathy, M.D., who will serve as the new department chair, and V. Craig Jordan, Ph.D., the developer of a number of proven cancer therapies. The two new recruits will be joining MD Anderson officially this Fall. One of Jordan’s ...

Read More »

Prostate Cancer Prevention Trial Studies Factors That Influence Men to Undergo Biopsies

Prostate Cancer Prevention Trial Studies Factors That Influence Men to Undergo Biopsies

SW—OG, a National Cancer Institute supported organization that conducts clinical trials in adult cancers, recently completed a study called the Prostate Cancer Prevention Trial, which revealed that healthy male participants that went through all the necessary steps of the trial have a higher likelihood of undergoing a preventive biopsy. This study, entitled “Factors Associated with Adherence to an End-of-Study Biopsy: Lessons from ...

Read More »

BCM, MD Anderson Study Highlights Genetic Alterations Found In An Aggressive Breast Cancer Subtype

BCM, MD Anderson Study Highlights Genetic Alterations Found In An Aggressive Breast Cancer Subtype

Researchers from the Lester and Sue Smith Breast Center at Baylor College of Medicine and the University of Texas MD Anderson Cancer Center have identified genetic alterations thought to contribute to the development of more aggressive forms of breast cancer. The study, entitled “Recurrent ​ESR1–​CCDC170 rearrangements in an aggressive subset of ​estrogen receptor-positive breast cancers,” was published in the acclaimed journal Nature Communications and led by ...

Read More »

MD Anderson Researcher Involved in I-Spy Trial Supports pCR Effect in Cancer Treatment

MD Anderson Researcher Involved in I-Spy Trial Supports pCR Effect in Cancer Treatment

Cancer researcher Don Berry, PhD, from the University of Texas M.D. Anderson Cancer Center recently weighed in on the results taken from the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO) trial fallout, which have generated controversy among the medical and pharmaceutical community. The ALTTO study showed that when lapatinib (Tykerb/Tyverb) is added to the standard form of trastuzumab (also known as Herceptin) ...

Read More »

Dr. Li Ma Highlights Breast Cancer Radioresistance With Protein ZEB1 at MD Anderson Cancer Center

Dr. Li Ma Highlights Breast Cancer Radioresistance With Protein ZEB1 at MD Anderson Cancer Center

Dr. Li Ma, PhD, an assistant professor at The University of Texas MD Anderson Cancer Center, is figuring out ways to battle breast cancer by studying breast cancer cell resistance to radiation. Her group of researchers recently discovered that the protein called zinc finger E-box binding homeobox 1 (ZEB1) may allow breast cancer cells to persist despite radiation treatment. “Radiation ...

Read More »

MD Anderson Partners With Brazilian Hospital To Eliminate Cancer Globally

MD Anderson Partners With Brazilian Hospital To Eliminate Cancer Globally

The University of Texas MD Anderson Cancer Center recently partnered with Brazilian-based Hospital Israelita Albert Einstein (HIAE) to pioneer multidisciplinary cancer patient care in Brazil, while meeting MD Anderson’s goal of eliminating cancer on a global scale. The private hospital, located in São Paulo, is one of the most respected health institutions in Latin America. HIAE began investing in cutting-edge medical technology early ...

Read More »

Hepatitis C Predicted To Be a Rare Disease By 2036

Hepatitis C Predicted To Be a Rare Disease By 2036

The University of Texas MD Anderson Cancer Center and the University of Pittsburgh Graduate School of Public Health have conducted a computer simulation predicting that hepatitis C will be reduced to that of a rare disease by 2036 if effective new drugs and screening techniques are used. A full report on the results of the simulation was recently published in the ...

Read More »

XBiotech Announces Launch of Phase III European Registration Study For Xilonix as a Colorectal Cancer Treatment

XBiotech Announces Launch of Phase III European Registration Study For Xilonix as a Colorectal Cancer Treatment

Austin-based XBiotech recently announced in a press release that it has enrolled the first patient in the company’s European Phase III clinical trial of Xilonix, a first-in-class “True Human” monoclonal antibody targeting interleukin-alpha1 for the treatment of colorectal cancer, the third most commonly diagnosed cancer and the third leading cause of cancer death worldwide. In 2013, the company had announced the beginning ...

Read More »

Houston-based MolecularMatch Hires Executive Team And Closes Series A Funding

Houston-based MolecularMatch Hires Executive Team And Closes Series A Funding

Houston-based MolecularMatch has completed the build-out of its executive team and rounded out its Series A funding, with its most recent investment coming from University of Texas Horizons Venture Fund, the company recently announced in a press release. MolecularMatch will use the funding, totaling $3.7 million, to develop a genomic-aware web application designed to pinpoint the best therapies and clinical ...

Read More »

MD Anderon Reviewed Study Reveals Bevacizumab/lomustine Combination Improved Recurrent Glioblastoma Outcomes

MD Anderon Reviewed Study Reveals Bevacizumab/lomustine Combination Improved Recurrent Glioblastoma Outcomes

The importance of targeting angiogenesis in glioblastoma has been the focus of a recent review by Dr. Mark Gilbert, MD, University of Texas MD Anderson Cancer Center, published in The Lancet Oncology journal, where a clinical study developed by a team of researchers from the Erasmus MC Cancer Institute, Rotterdam, Netherlands was analyzed. In this randomized, three-arm, multi-center, open-label phase ...

Read More »

Breast Cancer Genome Variety Profiled Using New Sequencing Approach

Breast Cancer Genome Variety Profiled Using New Sequencing Approach

Each of the cells in breast cancer tumors have different genomes and, depending on the tumor cell, they can grow in different rhythms, according to new research led by Nicholas Navin, Ph.D., an assistant professor in the Department of Genetics at The University of Texas M.D. Anderson Cancer Center in Houston. As part of the study, the scientists developed a new sequencing approach, revealing that the different subtypes of breast ...

Read More »
Scroll To Top
Close